Full history for every metric is available with a Kvantra account

Stock profile

YanAn Bicon Pharmaceutical Listed Company (002411.SZ)

Country: ChinaSector: Basic MaterialsIndustry: ChemicalsExchange: SHZ

Delisted · last close 11 Jul 2023

Current price
0.64 CNY-7.25%
Last close 11 Jul 2023
Benchmarks

Key financial summary

Financials in CNY
201720182019202020212022TTM
Total revenueCNY m5,3688,4479,3286,9407,6638,1067,058
Operating profitCNY m343-1,720
Net profitCNY m893404355-1,073-660-1,055-1,561
EPS reportedCNY-0.66-0.98
Operating cashflow per shareCNY1.831.83
Capex per shareCNY0.910.91
FCF per shareCNY0.920.92
Free cash flowCNY m1,472-3,059
Net debtCNY m8351,207
Book value equityCNY m5,7735,625
Book value per shareCNY3.613.67
Number of sharesm1,600.461,531.69
DPS (TTM paid)CNY1.260.00

Financial summary

Financials in CNY
201720182019202020212022TTM
Value
P/E TTMx--
P/B LTMx1.930.17
P/S LTMx1.370.13
P/FCF LTMx7.57-0.31
EV/EBITDA LTMx-11.76-7.95
EV/Sales LTMx1.490.31
Earnings Yield LTM%-9.47%-106.29%
FCF Yield%13.22%-322.01%
Quality
ROE%-18.27%-15.74%
ROIC%2.60%2.60%
Operating margin%4.23%4.23%
Gross margin%25.06%25.06%
FCF/Sales%18.16%18.16%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%+5.78%-16.76%
Net Income Growth YoY%--
FCF Growth%+359.71%-
Operating Profit Growth%-71.89%-
Dividend and capital structure
Dividend Yield%18.15%0.00%
Dividend Growth%--
Payout Ratio%-191.66%-134.80%
FCF/Debtx0.82-1.72
Net Debt/EBITDAx-0.89-0.89
EBIT/Net interestx1.211.21
Net debt/market cap%7.49%127.01%
Net debt/Equityx0.140.21
Gross debt/equityx0.310.32

Company overview

YanAn Bicon Pharmaceutical Listed Company operates as a Chinese entity focused on the entire lifecycle—from research and development to production and distribution—of pharmaceutical intermediates, pesticide intermediates, and advanced energy and materials products. Its product portfolio features medical goods sold under the "Bikangweizheng" and "DoctorBaby" brand names. The company's product offerings include lithium hexafluorophosphate, a key constituent for lithium-ion battery electrolytes. Beyond this, it manufactures and supplies various high-performance composite materials. These composite materials are integral to numerous applications, including but not limited to cut-resistant gloves, home textile items, cables, fishing nets, outdoor sportswear, bulletproof helmets, stab-resistant clothing, as well as components for military and aerospace industries, ocean-going vessels, naval ship ropes, deep-sea fishing trawls, anti-wind wave cages, sporting equipment, and construction engineering reinforcement. Among its pharmaceutical intermediates are triclopyridine sodium, 5,5-dimethylhydantoin, and benzaldehyde. Established in 2007 and headquartered in Xi'an, China, the company underwent a name change in October 2018. Previously known as JiangSu Bicon Pharmaceutical Listed Company, it adopted its current designation, YanAn Bicon Pharmaceutical Listed Company. It was formerly an affiliate of Xinyi Bicon New Medicine Industry Complex Investment Co., Ltd.

WebsiteN/A
IndustryChemicals
CountryChina
Trades inCNY

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 11 Jul 2023

YanAn Bicon Pharmaceutical Listed Company (002411.SZ)

002411.SZ · SHZ · Basic Materials
0.64 CNY-7.25%
Benchmarks
Financialsin CNY
20212022TTM
About

YanAn Bicon Pharmaceutical Listed Company operates as a Chinese entity focused on the entire lifecycle—from research and development to production and distribution—of pharmaceutical intermediates, pesticide intermediates, and advanced energy and materials products. Its product portfolio features medical goods sold under the "Bikangweizheng" and "DoctorBaby" brand names. The company's product offerings include lithium hexafluorophosphate, a key constituent for lithium-ion battery electrolytes. Beyond this, it manufactures and supplies various high-performance composite materials. These composite materials are integral to numerous applications, including but not limited to cut-resistant gloves, home textile items, cables, fishing nets, outdoor sportswear, bulletproof helmets, stab-resistant clothing, as well as components for military and aerospace industries, ocean-going vessels, naval ship ropes, deep-sea fishing trawls, anti-wind wave cages, sporting equipment, and construction engineering reinforcement. Among its pharmaceutical intermediates are triclopyridine sodium, 5,5-dimethylhydantoin, and benzaldehyde. Established in 2007 and headquartered in Xi'an, China, the company underwent a name change in October 2018. Previously known as JiangSu Bicon Pharmaceutical Listed Company, it adopted its current designation, YanAn Bicon Pharmaceutical Listed Company. It was formerly an affiliate of Xinyi Bicon New Medicine Industry Complex Investment Co., Ltd.

IndustryChemicals
CountryChina
Trades inCNY

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free